The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

A multidisciplinary panel convened by the ACR has developed a set of quality measures aimed at boosting rates of appropriate follow-up care for patients with noncritical but actionable incidental findings.

Computer-aided detection boosted by AI has often proven superior to traditional CAD over the past decade, yet the “new way” has been slow to win broad adoption.

Another teaching hospital has quickly and safely reduced its reliance on iodinated contrast media (ICM) by around 50% and taken to the pages of JACR to tell how they did it.

Researchers at a quaternary academic medical center have developed a short-term workaround that they report is now reducing the institution’s consumption of Omnipaque (iohexol) by more than 50% without compromising care quality.

The American Hospital Association is asking GE Healthcare to more fully apprise AHA’s nearly 5,000 member organizations of what the company is doing to help ameliorate the ongoing disruption in supplies of Omnipaque (iohexol).

We surveyed radiologists, administrators and others radiology professionals to learn more about the overall health of the specialty in 2022 and beyond. 

Radiology practice leaders who begrudge requests for parental and medical leave—if any such leaders are still extant in 2022—received a bracing wakeup call in late April.